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Can extended cost-eﬀ ectiveness analysis guide the scale-up of 
essential health services towards universal health coverage?
Appropriate ways to prioritise investments in health 
services has always been a challenge for countries, 
with various devices used based on whether whether 
the rationale is mainly economic or social. The present 
health focus calls for both a social and economic 
perspective, since universal health coverage dimensions 
are built from both viewpoints. In their Article in 
The Lancet Global Health, Stéphane Verguet and 
colleagues present interesting perspectives about the 
prioritisation of services as countries move towards 
universal health coverage.1 Using extended cost-
eﬀ ectiveness analysis, Verguet and colleagues compare 
nine common interventions in Ethiopia in terms of the 
numbers of deaths prevented (health gains) and cases 
of poverty averted (ﬁ nancial risk protection aﬀ orded). 
Their ﬁ ndings show that vaccination and caesarean 
section avert the most deaths per US$100 000 
spent (measles vaccination averts 367 deaths per 
$100 000 spent, pneumococcal conjugate vaccination 
averts 170, and caesarean section averts 141), whereas 
caesarean section, tuberculosis treatment, and 
hypertension treatment prevent the most cases of 
poverty per $100 000 spent. Their approach enables the 
prioritisation of interventions that usually score poorly 
in traditional cost-eﬀ ectiveness approaches but have 
major eﬀ ects on household economies.
Ethiopia is faced with challenging circumstances. It is 
a low-income country, with a gross domestic product 
estimated by the International Monetary Fund at 
US$570 per person in 2014,2 and 66% of the population 
living on less than US$2 per day in 20113—rates that are 
even lower than the averages for sub-Saharan Africa.
The population’s health status is also poor overall, 
with a healthy life expectancy at birth of 55 years and 
an under-5 mortality rate of 55 per 1000 livebirths.4 
The high rates of poverty and mortality in Ethiopia 
allows such an extended cost-eﬀ ectiveness analysis to 
contribute to the ongoing debate about intervention 
prioritisation in the country.
We recognise the diﬃ  culty in obtaining quality data in 
a low-income country for such an analysis—a challenge 
that Verguet and colleagues have also acknowledged. 
Additionally, to provide guidance for attainment of 
universal health coverage, the approach would need 
to be applied to a much wider range of interventions 
than the nine included in this study—a process that 
would generate more data and operational challenges 
than are focused on at present. For this approach 
to become more widely applicable, better methods 
to generate data proxies are needed in situations 
where routine data collection is diﬃ  cult. However, we 
believe that, irrespective of these challenges, countries 
should explore this approach in their decision-making 
processes, especially in situations of high poverty and 
mortality, for several reasons.
First, this analysis approach creates important links 
between the priorities of economists and health 
decision-makers in countries, combining social and 
economic aspects into the decision-making space. 
Emergent priorities respond to the expectations of both 
aspects, allowing convergence of ideas about where and 
why to invest in health.
Second, Verguet and colleagues’ paper provides a basis 
for taking forward guidance about a highly topical issue 
in health at present: universal health coverage. It can 
guide countries about how to increase the number of 
services provided in a manner that does not impoverish 
households, which combines two of the three aims of 
universal health coverage.5,6
Third, the article allows a more balanced analysis 
of the value of diﬀ erent investments in health. The 
traditional approach of prioritising public health 
versus clinical or curative interventions is called into 
question when we see the high value of interventions 
that are not traditionally part of countries’ basic 
packages. It emphasises the need for countries to 
establish priorities from across a comprehensive set 
of interventions—not just public health ones—to help 
guide movement towards comprehensive essential 
packages.
Finally, Verguet and colleagues’ study shows the value 
in prioritisation of interventions that do not necessarily 
cause signiﬁ cant mortality but have high costs or 
consequences when they occur. The ongoing global 
experience with Ebola virus disease illustrates this; such 
an analysis would most probably have provided high 
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scores for the types of interventions that countries 
needed to have made before the outbreak to reduce the 
epidemic’s impacts and costs.
To move forward, the discussion around essential 
services needs to move away from deﬁ ning a set of basic 
services towards a more comprehensive set of essential 
health services. This can be achieved by shifting the 
analytical focus away from a speciﬁ c set of services and 
towards an analysis of the comprehensive package of 
services as a means to guide how it can be rolled out. 
The analysis would then inform countries on how to 
progressively introduce additional essential health 
services to their existing package, based on value for 
money. We recognise that there will be associated data 
challenges with this approach, but data proxies and best 
estimates can be used as data collection systems are 
strengthened. More robust sensitivity analyses could be 
undertaken to improve the predictability of the results. 
Such methods call for a shift from sensitivity across a 
set data range, towards a focus on identifying at what 
levels the presented results would change, to provide 
what minimum and maximum amounts of intervention 
coverage would provide the best value for money.
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